MIGVAX

MigVax was established in 2020 via a leading investment from OurCrowd, the crowdfunding venture investment platform, MigVax set out to modify a well-established coronavirus vaccine developed by Migal for the immunization of poultry, and to use its advanced methodologies to create its innovative oral subunit vaccine for the immunization of humans, starting with the COVID-19... MigVax, a SPV by MIGAL is developing a vaccine for COVID-19, Coronavirus in human.

Also known as: MigVax Ltd.